Volume 68, Issue 5, Pages (November 2005)

Slides:

Advertisements

Similar presentations

Renal neuronal nitric oxide synthase protein expression as a marker of renal injury Attila J. Szabo, Laszlo Wagner, Aaron Erdely, Kim Lau, Chris Baylis.

Advertisements

Volume 65, Issue 6, Pages (June 2004)

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

Anemia management in chronic kidney disease

Volume 66, Issue 4, Pages (October 2004)

MyPlate for Healthy Eating With Chronic Kidney Disease (MyPlate Education for Patients With Chronic Kidney Disease Receiving Hemodialysis and Peritoneal.

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Volume 67, Issue 5, Pages (May 2005)

Volume 85, Issue 3, Pages (March 2014)

Volume 62, Issue 5, Pages (November 2002)

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Volume 57, Issue 6, Pages (June 2000)

Volume 61, Issue 5, Pages (May 2002)

Volume 71, Issue 11, Pages (June 2007)

Berthil H. C. M. T. Prinsen, Monique G. M

Margus Annuk, Mihkel Zilmer, Bengt Fellström

Arginase in glomerulonephritis

Toshimitsu Niwa, Naohito Takeda, Hideo Yoshizumi Kidney International

Volume 70, Issue 12, Pages (December 2006)

James D. House, Margaret E. Brosnan, John T. Brosnan

Relationship between methylmalonic acid and cobalamin in uremia

Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Blood pressure targets in hemodialysis patients

Altered tryptophan metabolism and CKD-associated fatigue

Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra

Volume 86, Issue 2, Pages (August 2014)

Volume 65, Issue 6, Pages (June 2004)

Albumin-like material in urine

Volume 67, Issue 5, Pages (May 2005)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Nitric oxide in acute renal failure: NOS versus NOS

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Alternate-day dialysis may be needed for hemodialysis patients

Methods for guideline development

AGEs in foods: Do they play a role in uremia?

Thomas Mueller, Benjamin Dieplinger Kidney International

Volume 56, Issue 2, Pages (August 1999)

Volume 56, Issue 5, Pages (November 1999)

Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,

Shannon D. Smith, Marcia A. Wheeler, Marc I. Lorber, Robert M. Weiss

H+-ATPase activity on unilateral ureteral obstruction: Interaction of endogenous nitric oxide and angiotensin II Patricia G. Valles, Walter A. Manucha

Volume 56, Issue 6, Pages (December 1999)

Daily nocturnal home hemodialysis

Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu Kidney International

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 69, Issue 1, Pages (January 2006)

Volume 56, Pages S84-S87 (November 1999)

Volume 80, Issue 10, Pages (November 2011)

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction Malcolm F. Hand, William G. Haynes, David J.

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 5, Pages (November 2003)

Volume 60, Issue 6, Pages (December 2001)

Volume 70, Issue 7, Pages (October 2006)

Is complement a target for therapy in renal disease?

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 62, Issue 5, (November 2002)

Adiponectin: good, bad, or just plain ugly?

Volume 70, Issue 10, Pages (November 2006)

Antioxidant therapy in hemodialysis patients: a systematic review

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Rebound kinetics of β2-microglobulin after hemodialysis

Jurgen Schnermann, Josephine P. Briggs Kidney International

Volume 61, Issue 4, Pages (April 2002)

Volume 60, Issue 6, Pages (December 2001)

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

Presentation transcript:

Volume 68, Issue 5, Pages 2173-2179 (November 2005) Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients Clarissa Demézio Da Silva, Tatiana M.C. Brunini, Patricia F. Reis, Monique B. Moss, Sergio F.F. Santos, Norman B. Roberts, John C. Ellory, Giovanni E. Mann, Antonio C. Mendes-Ribeiro Kidney International Volume 68, Issue 5, Pages 2173-2179 (November 2005) DOI: 10.1111/j.1523-1755.2005.00673.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Effects of malnutrition on L-arginine transport in platelets from chronic renal failure (CRF) patients on hemodialysis. Kinetics of L-arginine transport in platelets isolated from age-matched, healthy controls (N = 8) and chronic renal failure patients on hemodialysis (N = 16). Vmax values for system y+ L mediated L-arginine transport are shown. Data denote the mean ± SEM. Kidney International 2005 68, 2173-2179DOI: (10.1111/j.1523-1755.2005.00673.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Effects of malnutrition on basal L-[3H]-citrulline production (A) and cyclic guanosine monophosphate (cGMP) levels (B) in platelets from age-matched, healthy controls (N = 6 to 8) and well-nourished (N = 6 to 10) and malnourished (N = 6 to 8) chronic renal failure (CRF) patients on hemodialysis. Data denote the mean ± SEM. NOS is nitric oxide synthase. Kidney International 2005 68, 2173-2179DOI: (10.1111/j.1523-1755.2005.00673.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Platelet aggregation in platelet-rich plasma induced by collagen. Platelets were obtained from age-matched, healthy controls (N = 8), well-nourished (N = 8), and malnourished (N = 6) chronic renal failure patients (CRF) on hemodialysis. Data denote the means ± SEM. Kidney International 2005 68, 2173-2179DOI: (10.1111/j.1523-1755.2005.00673.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Plasma amino acid concentrations in chronic renal failure (CRF) patients. High-performance liquid chromatography (HPLC) measurements of amino acid concentrations in plasma from age-matched, healthy controls (N = 10) and well-nourished (N = 10) or malnourished (N = 10) chronic renal failure patients on hemodialysis (N = 20). Data denote the means ± SEM. Kidney International 2005 68, 2173-2179DOI: (10.1111/j.1523-1755.2005.00673.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Tumor necrosis factor-α (TNF-α) levels in plasma from control and chronic renal failure (CRF) patients. Data denote mean ± SEM of measurements in controls (N = 6), well-nourished (N = 6), and malnourished (N = 6) uremic patients. Kidney International 2005 68, 2173-2179DOI: (10.1111/j.1523-1755.2005.00673.x) Copyright © 2005 International Society of Nephrology Terms and Conditions